• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤肿瘤微环境细胞中PD-L1、CD4+和CD8+肿瘤浸润淋巴细胞(TILs)的表达谱

PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells.

作者信息

Caraban Bogdan Marian, Matei Elena, Cozaru Georgeta Camelia, Aşchie Mariana, Deacu Mariana, Enciu Manuela, Bălţătescu Gabriela Izabela, Chisoi Anca, Dobrin Nicolae, Petcu Lucian, Gheorghe Emma, Hangan Laurențiu-Tony, Roșu Mihai Cătălin, Orasanu Cristian Ionuț, Nicolau Antonela-Anca

机构信息

Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.

Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, "Ovidius" University of Constanta, 900591 Constanta, Romania.

出版信息

J Pers Med. 2023 Jan 27;13(2):221. doi: 10.3390/jpm13020221.

DOI:10.3390/jpm13020221
PMID:36836455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9965691/
Abstract

(1) Background: Because melanoma is an aggressive tumor with an unfavorable prognosis, we aimed to characterize the PD-L1 expression in melanomas in association with T cell infiltrates because PD-1/PD-L1 blockade represents the target in treating melanoma strategy. (2) Methods: The immunohistochemical manual quantitative methods of PD-L1, CD4, and CD8 TILs were performed in melanoma tumor microenvironment cells. (3) Results: Most of the PD-L1 positive, expressing tumors, have a moderate score of CD4+ TILs and CD8+TILs (5-50% of tumor area) in tumoral melanoma environment cells. The PD-L1 expression in TILs was correlated with different degrees of lymphocytic infiltration described by the Clark system (X = 8.383, = 0.020). PD-L1 expression was observed often in melanoma cases, with more than 2-4 mm of Breslow tumor thickness being the associated parameters (X = 9.933, = 0.014). (4) Conclusions: PD-L1 expression represents a predictive biomarker with very good accuracy for discriminating the presence or absence of malign tumoral melanoma cells. PD-L1 expression was an independent predictor of good prognosis in patients with melanomas.

摘要

(1) 背景:由于黑色素瘤是一种侵袭性肿瘤,预后不佳,我们旨在研究黑色素瘤中PD-L1表达与T细胞浸润的关系,因为PD-1/PD-L1阻断是治疗黑色素瘤策略的靶点。(2) 方法:采用免疫组织化学手工定量方法检测黑色素瘤肿瘤微环境细胞中的PD-L1、CD4和CD8肿瘤浸润淋巴细胞(TILs)。(3) 结果:在肿瘤性黑色素瘤环境细胞中,大多数PD-L1阳性表达肿瘤的CD4+TILs和CD8+TILs评分中等(占肿瘤面积的5-50%)。TILs中的PD-L1表达与Clark系统描述的不同程度淋巴细胞浸润相关(X = 8.383,P = 0.020)。在黑色素瘤病例中经常观察到PD-L1表达,Breslow肿瘤厚度超过2-4 mm是相关参数(X = 9.933,P = 0.014)。(4) 结论:PD-L1表达是一种预测生物标志物,在鉴别恶性肿瘤性黑色素瘤细胞的有无方面具有很高的准确性。PD-L1表达是黑色素瘤患者预后良好的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/b7f81318dd42/jpm-13-00221-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/b78c9bc8acfb/jpm-13-00221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/c32c25e4c272/jpm-13-00221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/be382104408a/jpm-13-00221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/cadb08fe72d8/jpm-13-00221-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/98a55199b5cf/jpm-13-00221-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/b7f81318dd42/jpm-13-00221-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/b78c9bc8acfb/jpm-13-00221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/c32c25e4c272/jpm-13-00221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/be382104408a/jpm-13-00221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/cadb08fe72d8/jpm-13-00221-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/98a55199b5cf/jpm-13-00221-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a12/9965691/b7f81318dd42/jpm-13-00221-g006.jpg

相似文献

1
PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells.黑色素瘤肿瘤微环境细胞中PD-L1、CD4+和CD8+肿瘤浸润淋巴细胞(TILs)的表达谱
J Pers Med. 2023 Jan 27;13(2):221. doi: 10.3390/jpm13020221.
2
The relationships between PD-L1 expression, CD8+ TILs and clinico-histomorphological parameters in malignant melanomas.PD-L1 表达、CD8+ TILs 与恶性黑色素瘤临床组织形态学参数之间的关系。
Pathol Res Pract. 2020 Sep;216(9):153071. doi: 10.1016/j.prp.2020.153071. Epub 2020 Jun 20.
3
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
4
Identification and validation of a novel survival prediction model based on the T-cell phenotype in the tumor immune microenvironment and peripheral blood for gastric cancer prognosis.基于肿瘤免疫微环境和外周血 T 细胞表型鉴定和验证用于胃癌预后的新型生存预测模型。
J Transl Med. 2023 Feb 3;21(1):73. doi: 10.1186/s12967-023-03922-0.
5
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.肿瘤 PD-L1 表达联合 CD8 肿瘤浸润淋巴细胞对高级别浆液性卵巢癌的预后价值。
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
6
Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.日光性唇炎和下唇鳞状细胞癌微环境中 PD-L1、CD4+ 和 CD8+ 细胞浸润及肿瘤浸润淋巴细胞(TILs)的免疫表达。
J Appl Oral Sci. 2022 Feb 21;30:e20210344. doi: 10.1590/1678-7757-2021-0344. eCollection 2022.
7
Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.程序性死亡配体 1 表达和肿瘤浸润淋巴细胞在轴性骨肉瘤中的预后意义。
World Neurosurg. 2019 Sep;129:e240-e254. doi: 10.1016/j.wneu.2019.05.121. Epub 2019 May 22.
8
Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians.肢端黑色素瘤中肿瘤微环境的临床意义:一项针对高加索人的大型单机构研究
J Clin Med. 2021 Apr 1;10(7):1452. doi: 10.3390/jcm10071452.
9
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.肿瘤浸润淋巴细胞(TILs)和PD-1/PD-L1免疫检查点在人脑转移瘤中的分布及其预后相关性
Oncotarget. 2015 Dec 1;6(38):40836-49. doi: 10.18632/oncotarget.5696.
10
High tumoral PD-L1 expression and low PD-1 or CD8 tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.高肿瘤 PD-L1 表达和低 PD-1 或 CD8 肿瘤浸润淋巴细胞预示原发性中枢神经系统弥漫性大 B 细胞淋巴瘤预后不良。
Oncoimmunology. 2019 Jun 10;8(9):e1626653. doi: 10.1080/2162402X.2019.1626653. eCollection 2019.

引用本文的文献

1
Tumor Microenvironment in Melanoma-Characteristic and Clinical Implications.黑色素瘤中的肿瘤微环境——特征与临床意义
Int J Mol Sci. 2025 Jul 15;26(14):6778. doi: 10.3390/ijms26146778.
2
Identification and analysis of immune cell-related genes in cutaneous squamous cell carcinoma and drug network prediction.皮肤鳞状细胞癌中免疫细胞相关基因的鉴定与分析及药物网络预测
Arch Dermatol Res. 2024 Dec 30;317(1):158. doi: 10.1007/s00403-024-03587-9.
3
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.

本文引用的文献

1
Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis.前列腺肿瘤发生过程中肿瘤微环境及相关生物学过程的特征分析
Biomedicines. 2022 Jul 12;10(7):1672. doi: 10.3390/biomedicines10071672.
2
Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.肿瘤淋巴管侵犯的机制及临床意义。
Cells. 2021 Sep 29;10(10):2585. doi: 10.3390/cells10102585.
3
Biomarkers involved in evaluation of platelets function in South-Eastern Romanian patients with hematological malignancies subtypes.
通过靶向程序性死亡受体配体1(PD-L1)攻击肿瘤细胞和免疫抑制细胞的实体癌导向嵌合抗原受体(CAR)T细胞疗法。
Mol Ther Oncol. 2024 Oct 5;32(4):200891. doi: 10.1016/j.omton.2024.200891. eCollection 2024 Dec 19.
4
Apoptosis-Cell Cycle-Autophagy Molecular Mechanisms Network in Heterogeneous Aggressive Phenotype Prostate Hyperplasia Primary Cell Cultures Have a Prognostic Role.异质性侵袭表型前列腺增生原代细胞培养物中细胞凋亡-细胞周期-自噬分子机制网络具有预后作用。
Int J Mol Sci. 2024 Aug 28;25(17):9329. doi: 10.3390/ijms25179329.
5
Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).肿瘤相关巨噬细胞在肝癌肿瘤微环境中的激活:特征与治疗(综述)。
Int J Oncol. 2024 Oct;65(4). doi: 10.3892/ijo.2024.5688. Epub 2024 Sep 6.
6
Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut-Liver Axis.肠-肝轴中免疫屏障失调相关 ROS 凋亡机制下内毒素对细胞的炎症作用。
Int J Mol Sci. 2024 Feb 20;25(5):2472. doi: 10.3390/ijms25052472.
7
A Narrative Review of Current Knowledge on Cutaneous Melanoma.关于皮肤黑色素瘤当前知识的叙述性综述
Clin Pract. 2024 Jan 26;14(1):214-241. doi: 10.3390/clinpract14010018.
8
A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.一种新型 PDPN 拮抗剂肽 CY12-RP2 通过 Wnt/β-catenin 抑制黑色素瘤生长,并调节免疫细胞。
J Exp Clin Cancer Res. 2024 Jan 2;43(1):9. doi: 10.1186/s13046-023-02910-y.
9
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.帕博利珠单抗联合化疗治疗转移性三阴性乳腺癌的 II 期临床试验,根据影像学缓解反应揭示了不同的转录组特征。
Clin Cancer Res. 2024 Jan 5;30(1):82-93. doi: 10.1158/1078-0432.CCR-23-1349.
评价罗马尼亚东南部血液系统恶性肿瘤亚型患者血小板功能的生物标志物。
Medicine (Baltimore). 2021 May 21;100(20):e25944. doi: 10.1097/MD.0000000000025944.
4
A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients.PD-L1在黑色素瘤中预后价值的汇总分析:来自1062例患者的证据
Cancer Cell Int. 2020 Mar 30;20:96. doi: 10.1186/s12935-020-01187-x. eCollection 2020.
5
Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.36 例原发性阴道黑色素瘤中 NRAS 突变、PD-L1 表达和扩增的发生率及总生存分析。
Oncologist. 2020 Feb;25(2):e291-e301. doi: 10.1634/theoncologist.2019-0148. Epub 2019 Oct 2.
6
Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania.罗马尼亚东南部患者结直肠癌中所选微小RNA的分子表达谱
Medicine (Baltimore). 2019 Nov;98(47):e18122. doi: 10.1097/MD.0000000000018122.
7
Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside.BRAF激酶抑制剂在黑色素瘤治疗中的意义:从实验室到临床
Cancers (Basel). 2019 Sep 11;11(9):1342. doi: 10.3390/cancers11091342.
8
Melanoma.黑素瘤。
J Surg Oncol. 2019 Oct;120(5):873-881. doi: 10.1002/jso.25604. Epub 2019 Jun 27.
9
Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer.程序性死亡受体 1 配体(PD-L1)表达升高预示着宫颈癌患者的生存结局较差。
Cancer Cell Int. 2019 May 23;19:146. doi: 10.1186/s12935-019-0861-7. eCollection 2019.
10
The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases.程序性细胞死亡蛋白 1/程序性细胞死亡配体 1 表达、CD3+T 细胞浸润、NY-ESO-1 表达、原发性皮肤黑色素瘤和黏膜黑色素瘤的微卫星不稳定性表型及其临床意义和预后价值:89 例连续病例研究。
Melanoma Res. 2020 Feb;30(1):85-101. doi: 10.1097/CMR.0000000000000620.